Jubilant Pharmova Limited

NSE:JUBLPHARMA.NS

1239 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q3
Revenue 17,42217,31717,58616,65216,66715,66516,608.715,332.215,847.414,404.715,144.3512,97616,336.816,134.515,516.8617,436.323,263.618,452.423,073.1722,798.922,365.521,527.823,521.4823,530.822,455.720,462.922,237.720,677.616,418.215,56315,990.814,388.113,59714,009.714,848.113,370.414,447.414,383.815,232.4814,302.513,621.114,605.315,516.2314,276.514,2434,930.313,882.913,018.112,095.84,357.212,202.7610,905.1
Cost of Revenue 5,54812,05311,8345,3595,5735,2015,297.74,780.74,8313,869.97,137.482,734.14,392.23,606.16,064.924,5848,505.86,19711,528.57,732.47,732.37,551.512,720.558,758.18,771.57,962.48,908.27,8686,0765,835.55,904.64,895.94,553.14,641.45,684.94,816.65,303.15,458.39,704.366,225.26,062.67,192.49,398.285,952.75,7024,930.35,884.765,3484,561.44,357.210,789.063,986.7
Gross Profit 11,8745,2645,75211,29311,09410,46411,31110,551.511,016.410,534.88,006.8710,241.911,944.612,528.49,451.9412,852.314,757.812,255.411,544.6715,066.514,633.213,976.310,800.9314,772.713,684.212,500.513,329.512,809.610,342.29,727.510,086.29,492.29,043.99,368.39,163.28,553.89,144.38,925.55,528.128,077.37,558.57,412.96,117.958,323.88,54107,998.147,670.17,534.401,413.76,918.4
Gross Profit Ratio 0.6820.3040.3270.6780.6660.6680.6810.6880.6950.7310.5290.7890.7310.7760.6090.7370.6340.6640.50.6610.6540.6490.4590.6280.6090.6110.5990.6190.630.6250.6310.660.6650.6690.6170.640.6330.6210.3630.5650.5550.5080.3940.5830.600.5760.5890.62300.1160.634
Reseach & Development Expenses 000000000001,2001,080000000000202.2000182.050000000000071.60000000000000
General & Administrative Expenses 0000003,534.10003,290.660002,951.4300000005,485.650004,892.190003,433.920003,015.410002,963.850001,450.38000909.8400000
Selling & Marketing Expenses 000000413000259.84000161.770000000315.74000274.14000293.26000232.46000168.670001,600.40001,232.8200000
SG&A 3,4383,6564,0483,4173,4945,4773,947.13,606.23,630.53,431.53,550.51,983.42,614.23,709.13,113.24,8215,5835,463.93,193.95,386.35,221.95,041.35,801.394,996.64,779.64,515.85,166.334,229.33,6883,103.23,727.183,091.63,014.12,9593,247.872,832.32,851.32,742.13,132.522,717.32,712.12,722.26,742.212,810.72,843.12,560.85,581.762,383.40000
Other Expenses 9,894-953144358998644.594.7131113.1-55.659.144.538.9-42.3235.972.881.3-164.7660.3122.697-297.72290.238.394.7229.132.270.968.1105.3194.1258185.622.4424.1183.1201.7-234.12152.389.9126-546.72151.3113.25,151.133.3545.8126.44,622.1-199.4347.4
Operating Expenses 9,8944,6094,04810,0599,6429,66511,831.110,035.59,768.49,556.56,040.669,232.89,547.49,656.45,856.628,884.111,054.410,356.27,440.3111,126.911,117.110,657.28,032.0210,824.110,077.29,004.510,568.29,459.48,071.77,076.27,779.67,043.46,569.56,544.67,501.56,620.56,827.96,497.13,702.677,1116,966.16,772.83,774.666,661.96,607.65,151.16,020.185,713.95,492.84,622.1-717.465,383
Operating Income 1,9806551,7041,7231,641799-308.5594.21,352.4978.31,4681,009.12,397.22,8723,595.323,968.23,703.41,899.24,104.363,939.63,516.13,319.12,768.913,948.63,6073,4962,761.33,350.22,270.52,651.32,306.62,448.82,474.42,823.71,661.71,933.32,316.42,428.41,825.45966.3592.4640.12,343.291,661.91,933.4-10,081.41,977.961,956.22,041.6-8,979.32,131.161,535.4
Operating Income Ratio 0.1140.0380.0970.1030.0980.051-0.0190.0390.0850.0680.0970.0780.1470.1780.2320.2280.1590.1030.1780.1730.1570.1540.1180.1680.1610.1710.1240.1620.1380.170.1440.170.1820.2020.1120.1450.160.1690.120.0680.0430.0440.1510.1160.136-2.0450.1420.150.169-2.0610.1750.141
Total Other Income Expenses Net -5364,342-2,275-713-661-547-555.6-506.9-988.4-287.7-411.3-306.8-316.8-406.9-1,037.96-567.7-566.7-678.2-544.85-1,006.4-593.8-628.8-3,168.7-392.5-588.9-632.3-495.7-738.4-589.2-619.2-696.6-784-540.1-641.1-972-533.7-768-742.9-1,147.51-810.3-823.6-839.6-907.36-589.8-2,210-1,797.3-1,793.78-1,207.5-104.10-2,358.29-2,076.4
Income Before Tax 1,4444,997-5711,010980252-864.187.3364690.61,056.67702.32,080.42,465.12,557.363,400.53,136.71,2213,559.512,933.22,922.32,690.3-399.793,556.13,018.12,863.72,265.62,611.81,681.32,032.11,6101,664.81,934.32,182.6689.71,399.61,548.41,685.5677.94156-231.2-199.51,435.931,072.1-276.6-10,081.4184.18748.71,937.5-8,979.3-227.13-541
Income Before Tax Ratio 0.0830.289-0.0320.0610.0590.016-0.0520.0060.0230.0480.070.0540.1270.1530.1650.1950.1350.0660.1540.1290.1310.125-0.0170.1510.1340.140.1020.1260.1020.1310.1010.1160.1420.1560.0460.1050.1070.1170.0450.011-0.017-0.0140.0930.075-0.019-2.0450.0130.0580.16-2.061-0.019-0.05
Income Tax Expense 41917981346359192141247.7314.8223.1465.81194.3654860.2830.581,211.6895.5340.9954.58899.4428.4840.5606.73880.9920.4860741.6483.4426.6595110.7479.9497.2542.4581.1230.3390.2404.9250.64202.2645.3-293.3352.34-488.251853.3428.5353.6352.8102.2350.7488.8
Net Income 1,0284,821-58666862564-978.4-156.754.9470.4595.46509.91,428.41,605.62,138.993,099.32,240.3880.12,604.962,033.82,493.91,849.8-992.942,608.42,104.12,0251,548.72,128.41,254.71,437.11,499.31,197.81,437.11,616108.61,169.31,158.21,280.6427.26-111.6-941.147.8988.11,434.3-805.8-10,134.7-309.73266.91,520-9,081.5-635.29-783.9
Net Income Ratio 0.0590.278-0.0330.040.0370.004-0.059-0.010.0030.0330.0390.0390.0870.10.1380.1780.0960.0480.1130.0890.1120.086-0.0420.1110.0940.0990.070.1030.0760.0920.0940.0830.1060.1150.0070.0870.080.0890.028-0.008-0.0690.0030.0640.1-0.057-2.056-0.0220.0210.126-2.084-0.052-0.072
EPS 6.4730.51-3.684.193.920.41-6.15-0.980.352.963.743.28.9710.0913.4319.4614.065.5316.3612.7715.6611.61-6.2416.7413.5139.9413.648.239.949.637.669.299.630.727.98.118.282.68-0.7-5.918.046.29-5.06-63.56-1.951.689.54-57.02-3.99-4.92
EPS Diluted 6.4630.35-3.684.193.920.41-6.15-0.980.342.963.743.28.9710.0913.4319.4614.065.5316.3612.7715.6611.61-6.2416.7413.5139.9413.648.239.949.637.669.299.630.727.898.18.282.68-0.7-5.918.046.29-5.06-63.56-1.951.689.54-57.02-3.99-4.92
EBITDA 2,9681,5622,7142,6692,6071,7682,403.81,5372,291.92,035.62,384.822,001.83,425.63,691.73,887.794,932.54,934.63,103.55,441.175,134.54,807.14,4433,515.435,222.84,540.14,470.74,807.84,200.63,131.53,444.23,164.13,369.43,452.53,724.52,951.73,103.93,250.53,332.22,039.161,913.71,374.11,496.62,362.292,545.92,756.8-9,399.22,500.122,633.82,788.3-8,388.72,593.642,121.7
EBITDA Ratio 0.170.090.1540.160.1560.1130.1450.10.1450.1410.1570.1540.210.2290.2510.2830.2120.1680.2360.2250.2150.2060.1490.2220.2020.2180.2160.2030.1910.2210.1980.2340.2540.2660.1990.2320.2250.2320.1340.1340.1010.1020.1520.1780.194-1.9060.180.2020.231-1.9250.2130.195